64
Participants
Start Date
July 22, 2014
Primary Completion Date
March 29, 2016
Study Completion Date
March 29, 2016
ADVATE (Antihemophilic Factor [Recombinant])
RIXUBIS (Coagulation Factor IX [Recombinant])
North Shore/Long Island Jewish PRIME, Great Neck
Children's Hospital of Philadelphia, Philadelphia
Johns Hopkins University School Of Medicine, Baltimore
The Presbyterian Hospital, Charlotte
The Vanderbilt Clinic, Nashville
University of Kentucky Medical Center, Lexington
Childrens Hospital of Michigan, Detroit
Michigan State University, East Lansing
Munson Medical Center, Traverse City
Bleeding and Clotting Disorders Institute, Peoria
Children's Mercy Hospitals & Clinics, Kansas City
The University of Texas MD Anderson, Harlingen
University of Colorado, Aurora
Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center, Los Angeles
Rady Childrens Hospital, San Diego
Oregon Health & Science University, Portland
Puget Sound Blood Center, Seattle
Baxalta now part of Shire
INDUSTRY